Newcastle University Protein and Proteome Analysis
NUPPA
Who we are
The Newcastle University Protein and Proteome Analysis (NUPPA) facility supports researchers with protein and proteome analysis both within and beyond the University. We collaborate with internal researchers as well as external academic and commercial partners, with a primary focus on discovery proteomics. Our workflows utilise both data-independent acquisition (DIA) and data-dependent acquisition (DDA) mass spectrometry methods, with the capability to develop more targeted assays such as multiple reaction monitoring (MRM) and parallel reaction monitoring (PRM) when required. Our instrumentation, including the Astral platform (acquired via MRC capital equipment grant), provides the potential to meet a wide range of analytical needs by delivering both high sensitivity and high throughput. The facility has extensive experience working with a diverse range of sample types, including cell lysates, immunoprecipitation (IP) pull-downs, bacterial lysates, gel bands, and clinical samples such as plasma, cerebrospinal fluid (CSF), and tissue.
Prices for external collaborators starts at £275 per sample; including sample processing, data acquisition and analysis.
O-Link Reveal accredited service provider
Olink Reveal enables researchers to explore biological pathways in human health and disease and identify biomarkers for disease progression and treatment monitoring. Because proteins are the key effectors of cellular processes, measuring their abundance in blood and other liquid biopsy samples provides direct insight into functional biology.
The platform uses high-plex, affinity-based proteomics to quantify ~1,000 carefully selected proteins in a single analysis, offering broad pathway coverage and deep immune profiling across a wide range of diseases and research areas.
How to submit a sample
To start a new project or submit a sample for analysis with NUPPA, or request accurate pricing, please contact us via email and be sure to include a contact for the appropriate unit to ensure most efficient response. Sample submission forms can be found here.
Key grants
Key Grants which underpin the facility:
- 2014-present: Taggart Group MRC, Cardiac Research (£728k) (_Proteomics_)
- 2018-2022: James Guest CoralAssist (>£1M) (_Proteomics_)
- 2017-2022: Grant Burgess Hereus NucB (£400K) (_ProteinProduction_)
- 2016-2019: John Issacs Rheumatoid Arthritis (£400K)(_Proteomics_)
- 2016-2020: Phil Brown Methotrexate Quantification (_Proteomics_)
Recent Publications
Tinning H, Taylor A, Wang D, Constantinides B, Sutton R, Oikonomou G, Velazquez MA, Thompson P, Treumann A, O'Connell MJ, Forde N. The role of CAPG in molecular communication between the embryo and the uterine endometrium: Is its function conserved in species with different implantation strategies? FASEB J. 2020 Jul 3. doi: 10.1096/fj.202000882RR. (Epub ahead of print) PMID: 32619075.
Lence E, Maneiro M, Sanz-Gaitero M, van Raaij MJ, Thompson P, Hawkins AR, González-Bello C. Self-Immolation of a Bacterial Dehydratase Enzyme by its Epoxide Product. Chemistry. 2020 Jun 26;26(36):8035-8044. doi: 10.1002/chem.202000759. Epub 2020 Jun 8. PMID: 32259333
Verheul, J. Yau H. LLodge A, Liu X., Solovyova AS, Typas A, Banzhaf M., Vollmer W, den Blaauwen T..Midcell localization of PBP4 of Escherichia coli is essential for the timing of the divisome (2020) submitted


